4//SEC Filing
REGENERON PHARMACEUTICALS INC 4
Accession 0001237899-15-000028
$REGNCIK 0000872589operating
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 4:20 PM ET
Size
17.4 KB
Accession
0001237899-15-000028
Insider Transaction Report
Form 4
BAKER CHARLES A
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2015-03-25−5,000→ 10,000 totalExercise: $18.61Exp: 2019-01-02→ Common Stock (5,000 underlying) - Sale
Common Stock
2015-03-25$457.21/sh−200$91,442→ 9,000 total - Sale
Common Stock
2015-03-25$454.38/sh−1,999$908,306→ 11,436 total - Sale
Common Stock
2015-03-25$455.48/sh−1,536$699,617→ 9,900 total - Sale
Common Stock
2015-03-25$456.36/sh−700$319,452→ 9,200 total - Exercise/Conversion
Common Stock
2015-03-25$18.61/sh+5,000$93,050→ 14,000 total - Sale
Common Stock
2015-03-25$452.45/sh−300$135,735→ 13,700 total - Sale
Common Stock
2015-03-25$453.71/sh−265$120,233→ 13,435 total
Footnotes (7)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]Represents volume-weighted average price of sales of 265 shares of Company stock on March 25, 2015 at prices ranging from $453.33 to $453.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 25, 2015 at each separate price.
- [F3]Represents volume-weighted average price of sales of 1,999 shares of Company stock on March 25, 2015 at prices ranging from $454.03 to $454.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 25, 2015 at each separate price.
- [F4]Represents volume-weighted average price of sales of 1,536 shares of Company stock on March 25, 2015 at prices ranging from $455.00 to $455.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 25, 2015 at each separate price.
- [F5]Represents volume-weighted average price of sales of 700 shares of Company stock on March 25, 2015 at prices ranging from $456.00 to $456.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 25, 2015 at each separate price.
- [F6]Represents volume-weighted average price of sales of 200 shares of Company stock on March 25, 2015 at prices ranging from $457.00 to $457.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 25, 2015 at each separate price.
- [F7]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000872589
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 4:20 PM ET
- Size
- 17.4 KB